YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder

Not Applicable

Terminated

Conditions: Post-Traumatic Stress Disorder

Interventions: Device: Experimental Feedback
Device: Control Feedback

First Posted Date: 2018-07-02

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 27

Registration Number: NCT03574974

Locations: 🇺🇸
VA Connecticut Healthcare System - West Haven Campus, West Haven, Connecticut, United States
🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Enhancement of Therapeutic Learning in OCD Using tDCS

Not Applicable

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Device: tDCS

First Posted Date: 2018-06-28

Last Posted Date: 2022-02-17

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT03572543

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Feasibility Pilot of Bright Light in the Intensive Care Unit

Not Applicable

Completed

Conditions: Circadian Rhythm Sleep Disorder, Unspecified

Interventions: Device: standard light
Device: 10,000 lux bright light, 4 hours
Device: 10,000 lux bright light, 8 hours

First Posted Date: 2018-06-26

Last Posted Date: 2024-06-17

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT03568045

Locations: 🇺🇸
Yale New Haven Hospital, York Street Campus, New Haven, Connecticut, United States

Examining Hepatitis C Reinfection Rates in Kenya

Completed

Conditions: Hepatitis C

First Posted Date: 2018-06-21

Last Posted Date: 2021-04-20

Lead Sponsor: Yale University

Target Recruit Count: 101

Registration Number: NCT03564639

Locations: 🇰🇪
NASCOP, Nairobi, Kenya

Inhibition of Sterile Inflammation by Digoxin

Phase 1

Completed

Conditions: Inflammatory Response

Interventions: Other: Placebo
Drug: Digoxin

First Posted Date: 2018-06-18

Last Posted Date: 2024-07-12

Lead Sponsor: Yale University

Target Recruit Count: 45

Registration Number: NCT03559868

Locations: 🇺🇸
Yale Centre of Clinical Investigation, New Haven, Connecticut, United States

Social Value Training in Toddlers With Elevated Autism Symptoms

Not Applicable

Terminated

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Social Value Learning Training

First Posted Date: 2018-06-14

Last Posted Date: 2023-12-19

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT03556826

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Phase 1

Active, not recruiting

Conditions: Major Depressive Disorder

Interventions: Drug: Low Dose Psilocybin
Drug: Placebo
Drug: Medium Dose Psilocybin

First Posted Date: 2018-06-13

Last Posted Date: 2024-05-28

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT03554174

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut, United States

Galantamine and CBT4CBT Pilot to Prevent Relapse.

Early Phase 1

Completed

Conditions: Methadone or Buprenorphine Detoxoxification

Interventions: Drug: MAT taper with galantamine
Drug: MAT taper with placebo

First Posted Date: 2018-06-06

Last Posted Date: 2022-08-19

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT03547622

Locations: 🇺🇸
APT Foundation, New Haven, Connecticut, United States

The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes

Not Applicable

Completed

Conditions: Type1diabetes

Interventions: Device: Quick Bolus
Device: Standard Bolus

First Posted Date: 2018-05-31

Last Posted Date: 2024-02-13

Lead Sponsor: Yale University

Target Recruit Count: 11

Registration Number: NCT03542682

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery

Not Applicable

Completed

Conditions: Urinary Incontinence
Pelvic Organ Prolapse

Interventions: Procedure: Retrograde bladder fill
Other: spontaneous void

First Posted Date: 2018-05-29

Last Posted Date: 2020-01-13

Lead Sponsor: Yale University

Target Recruit Count: 110

Registration Number: NCT03539107

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy